Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
S Mayanagi, M Kitago, T Sakurai, T Matsuda… - Cancer …, 2015 - Wiley Online Library
This study aimed to evaluate the feasibility of and immune response to Wilms tumor gene 1
(WT 1) peptide‐pulsed dendritic cell vaccination combined with gemcitabine (DCGEM) as a
first‐line therapy among patients with advanced pancreatic cancer. Ten HLA‐A* 2402 …
(WT 1) peptide‐pulsed dendritic cell vaccination combined with gemcitabine (DCGEM) as a
first‐line therapy among patients with advanced pancreatic cancer. Ten HLA‐A* 2402 …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论